Eulerpool/
Stock/
PAVmed/
FCF Conversion

PAVmed FCF Conversion

PAVM

The FCF Conversion Rate (FCF/EBITDA) of PAVmed (PAVM) as of Jul 30, 2026 is -1.30 M %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -84.46 % — a change of 1.54 M% (lower).

Get this data via API

Financial Data API

FCF Conversion

-1.30 M %

YoY

1.54 M%

Last updated: Jul 30, 2026

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE

FCF Conversion Rate (FCF/EBITDA) of PAVmed is 2026 -1.30 M % . FCF Conversion Rate (FCF/EBITDA) of PAVmed was 2025 -84.46 % . It decreases by 1.54 M% lower compared to the previous year.

PAVmed Free Cash Flow PAVmed EBITDA PAVmed FCF/Net Income PAVmed Cash Conversion

Access this data via the Eulerpool API

Docs Get Free API Key

PAVmed Stock analysis

What does PAVmed do? PAVmed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PAVmed stock

FCF Conversion Rate (FCF/EBITDA) of PAVmed is -1.30 M % in 2026.

FCF Conversion Rate (FCF/EBITDA) of PAVmed changed from -84.46 % to -1.30 M %, representing a 1.54 M% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) PAVmed since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s PAVmed with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Docs Get Free API Key